A novel, commercially available reverse hybridization assay [GenoType Mycobacteria Direct (GTMD), version 2.0; Hain Lifescience] was evaluated for the direct detection of five clinically relevant mycobacterial species [ complex (MTBC), , , and ] from 54 smear-positive respiratory specimens and the findings were compared with culture results. Three approaches were used for specimen preparation using either whole or ‘split’ sample volumes and -acetyl--cysteine/3 % NaOH or 4 % NaOH as decontamination chemicals. Forty-three out of 52 samples in which RNA amplification was successful gave GTMD results that concurred with the identification of the cultured isolate. All cases of MTBC were detected. Twenty-two samples contained complex, seven had , four had , seven contained atypical mycobacteria other than those detectable using the GTMD assay and three specimens contained no viable mycobacteria. The assay is easy to use and can be completed in one working day. Results interpretation is facilitated by the inclusion of an internal amplification control with each sample to allow identification of specimens containing amplification inhibitors. A positive GTMD result will quickly identify patients with MTBC infection or provide specific identification of four other atypical mycobacteria from the same specimen. This allows more rapid drug susceptibility testing, treatment, and public health and infection control decisions.


Article metrics loading...

Loading full text...

Full text loading...



  1. Falkinham J. O. III 1996; Epidemiology of infection by non-tuberculous mycobacteria. Clin Microbiol Rev 9:177–215
    [Google Scholar]
  2. Forbes B. A., Hicks K. E. 1996; Substances interfering with direct detection of Mycobacterium tuberculosis in clinical specimens by PCR: effects of bovine serum albumin. J Clin Microbiol 34:2125–2128
    [Google Scholar]
  3. Franco-Álvarez de Luna F., Ruiz P., Gutiérrez J., Casal M. 2006; Evaluation of the GenoType Mycobacteria Direct assay for detection of Mycobacterium tuberculosis complex and four atypical mycobacterial species in clinical samples. J Clin Microbiol 44:3025–3027 [CrossRef]
    [Google Scholar]
  4. Health Protection Agency Centre for Infections 2007; Tuberculosis in the UK: annual report on tuberculosis surveillance and control in the UK 2007. (last accessed 04 January 2008 http://www.hpa.org.uk/publications/2007/TB/TB_annual_report.pdf
  5. National Collaborating Centre for Chronic Conditions 2006 Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control London: Royal College of Physicians;
    [Google Scholar]
  6. Piersimoni C., Scarparo C. 2003; Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples. J Clin Microbiol 41:5355–5365 [CrossRef]
    [Google Scholar]
  7. Shakir E., Johnston F., McMenamin J. 2007; Enhanced surveillance of mycobacterial infections (ESMI) in Scotland: annual report for Scotland for the years 2004–2006. HPS Wkly Rep 41:374–380
    [Google Scholar]

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error